BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20408505)

  • 1. Total agranulocytosis caused by dapsone therapy for tuberculoid leprosy--an unappreciated serious side effect of anti-leprosy treatment with clinical implications.
    Satarasinghe RL; Jayawardana MA; De Silva GV; Murugathas S; Riyaaz AA; Wickrmasingha UD; Wijesinghe R
    Drug Metabol Drug Interact; 2009; 24(2-4):325-9. PubMed ID: 20408505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapsone-induced agranulocytosis in patients with Hansen's disease.
    Fernandes TRMO; Jesus BN; Barreto TT; Pereira AA
    An Bras Dermatol; 2017; 92(6):894-897. PubMed ID: 29364462
    [No Abstract]   [Full Text] [Related]  

  • 3. Dapsone agranulocytosis in a leprosy patient.
    Hiran S; Pande TK; Pani S; Vishwanathan KA
    Lepr Rev; 1994 Sep; 65(3):279-81. PubMed ID: 8942159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sparing of tuberculoid leprosy patch in a patient with dapsone hypersensitivity syndrome.
    Ng PP; Goh CL
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):646-8. PubMed ID: 9777777
    [No Abstract]   [Full Text] [Related]  

  • 5. Dapsone-induced agranulocytosis in a patient of leprosy.
    Mishra M; Chhetia R
    Indian J Dermatol Venereol Leprol; 2006; 72(6):456-7. PubMed ID: 17179627
    [No Abstract]   [Full Text] [Related]  

  • 6. Dapsone induced acute photosensitivity dermatitis; a case report and review of literature.
    De D; Dogra S; Kaur I
    Lepr Rev; 2007 Dec; 78(4):401-4. PubMed ID: 18309716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dapsone syndrome: an incomplete form.
    Jaswal R; Thami GP; Kanwar AJ
    Indian J Lepr; 1998; 70(2):229-30. PubMed ID: 9724867
    [No Abstract]   [Full Text] [Related]  

  • 8. Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity.
    Ranawaka RR; Mendis S; Weerakoon HS
    Lepr Rev; 2008 Dec; 79(4):436-40. PubMed ID: 19274991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agranulocytosis induced by multidrug therapy in leprosy treatment: a case report.
    Silva IM; Oliveira CA; Guedes WR; Oliveira BB; Oliveira DA; Guedes Filho G
    Braz J Infect Dis; 2009 Apr; 13(2):158-60. PubMed ID: 20140364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brazilian clinical trial of uniform multidrug therapy for leprosy patients: the correlation between clinical disease types and adverse effects.
    Gonçalves Hde S; Pontes MA; Bührer-Sékula S; Cruz R; Almeida PC; Moraes ME; Penna GO
    Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():74-8. PubMed ID: 23283457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case report of fatal dapsone-induced agranulocytosis in an Indian mid-borderline leprosy patient.
    Bhat RM; Radhakrishnan K
    Lepr Rev; 2003 Jun; 74(2):167-70. PubMed ID: 12862258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dapsone: An Update.
    Karjigi S; Murthy SC; Kallappa H; Kusuma MR; Aruna B; Reddy YN
    Indian J Lepr; 2016 Sep; 87(4):233-239. PubMed ID: 29762952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal hyperbilirubinemia after treatment of maternal leprosy.
    Thornton YS; Bowe ET
    South Med J; 1989 May; 82(5):668. PubMed ID: 2717998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial manifestation of tuberculoid leprosy in pregnancy. Guidelines for diagnosis and therapy].
    Neuer A; Spang E; Sticht-Groh V
    Geburtshilfe Frauenheilkd; 1996 Mar; 56(3):156-60. PubMed ID: 8674964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal dapsone hypersensitivity syndrome with hypothyroidism and steroid-induced diabetes mellitus.
    Pai S; Munshi R; Nayak C
    Indian J Pharmacol; 2017; 49(5):396-398. PubMed ID: 29515281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and electroneurophysiological assessment of leprosy patients on dapsone monotherapy--a two year follow-up study.
    Rao SP; Taori GM; Desikan KV; Nayar S
    Indian J Lepr; 1995; 67(2):167-76. PubMed ID: 8537705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of multidrug therapy in paucibacillary leprosy in Singapore.
    Lim JT; Tan T
    Lepr Rev; 1993 Jun; 64(2):136-42. PubMed ID: 8341116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dapsone syndrome with acute renal failure during leprosy treatment: case report.
    Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Fontes CJ
    Braz J Infect Dis; 2005 Feb; 9(1):84-6. PubMed ID: 15947852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: A Case of Type 1 Leprosy Reaction and Dapsone Hypersensitivity Syndrome Complicating the Clinical Course of Multibacillary Leprosy.
    Craig J; MacRae C; Melvin RG; Boggild AK
    Am J Trop Med Hyg; 2019 May; 100(5):1145-1148. PubMed ID: 30915953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.